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Sporozoites are a motile form of malaria-causing Plasmodium falciparum parasites 
that migrate from the site of transmission in the dermis through the bloodstream to 
invade hepatocytes. Sporozoites interact with many cells within the host, but the 
molecular identity of these interactions and their role in the pathology of malaria is 
poorly understood. Parasite proteins that are secreted and embedded within 
membranes are known to be important for these interactions, but our understanding 
of how they interact with each other to form functional complexes is largely unknown. 
Here, we compile a library of recombinant proteins representing the repertoire of cell 
surface and secreted proteins from the P. falciparum sporozoite and use an assay 
designed to detect extracellular interactions to systematically identify complexes. We 
identify three protein complexes including an interaction between two components of 
the p24 complex that is involved in the trafficking of glycosylphosphatidylinositol (GPI)-
anchored proteins through the secretory pathway. Plasmodium parasites lacking 
either gene are strongly inhibited in the establishment of liver stage infections. These 
findings reveal an important role for the p24 complex in malaria pathogenesis and 
show that the library of recombinant proteins represents a valuable resource to 
investigate P. falciparum sporozoite biology.  
 
 






Malaria is a deadly mosquito-borne infectious disease caused by unicellular Plasmodium 
parasites, and despite intensive control efforts is still responsible for almost half a million 
deaths annually (1). Critical to mosquito-human transmission is the sporozoite: a motile stage 
that develops within oocysts located on the midgut of infected mosquitoes before invading the 
mosquito salivary glands and being transmitted during a subsequent blood meal. Once 
deposited in the dermis, sporozoites disperse in apparently random directions before entering 
the circulation and eventually enter the liver where they invade hepatocytes and continue their 
development (2). Targeting the sporozoite is an attractive choice for vaccine development 
because sporozoites are extracellular and therefore directly exposed to the host humoral 
immune system, this stage of the infection is asymptomatic, and sporozoites are few in number 
since only tens to hundreds are transmitted (3-5). Importantly, malaria vaccines based on 
attenuated whole sporozoites, as well as a subunit vaccine incorporating components of the 
major sporozoite surface protein CSP, have been shown to be effective in human trials, 
although protection was typically short-lived (6). 
 
Proteins that are displayed on the surface of the parasite or released from intracellular 
secretory organelles such as the rhoptries and micronemes are considered good subunit 
vaccine targets because they are directly accessible to host antibodies. The main functions of 
these proteins are likely to be the subversion of the immune response or the interaction with 
host molecules to regulate different stages of infection; for example, to power parasite motility 
or bind specific receptors that control the tropism of host cell invasion. Because the blood 
stages of P. falciparum can be cultured in vitro, we have a comparatively good understanding 
of which parasite proteins are displayed on the surface of the merozoite and how they interact 
to form functional complexes. For example, the major merozoite surface protein MSP1 is found 
in a protein complex with MSP7 and MSP6 (7, 8), and the secreted P41 protein is tethered to 
 
 





the surface of the merozoite by the GPI-anchored P12 protein (9). Parasite protein complexes 
that are known to be essential for P. falciparum erythrocyte invasion include the interactions 
between AMA1 and RON2 (10) and more recently those proteins that directly bind RH5 
including CyRPA (11), RIPR (12), and P113 (13). Mechanistically, vaccine-elicited antibodies 
that target the components of these protein complexes on the parasite surface may neutralise 
blood stage parasites by inhibiting their function or formation (14). By contrast to the blood 
stages, however, relatively little is known about the biochemical composition and organisation 
of the sporozoite surface although genetic targeting has revealed that several parasite surface 
proteins are required for normal sporozoite development and infection. For example, 
circumsporozoite protein (CSP) is required for the development of sporozoites in the oocyst 
(15, 16), TRAP family proteins (TRAP and TLP) are important for sporozoite motility and 
infection (17, 18), and members of the 6-cys family (P36 and P52) are important for host 
receptor usage in hepatocyte invasion (19). While we have a good cellular description of how 
the sporozoite interacts with host cells (20), a molecular understanding of these behaviours is 
incomplete and yet could represent important new opportunities for pre-erythrocytic malaria 
vaccines.  
 
Identifying interactions between membrane-embedded proteins is challenging because 
membrane proteins are both amphipathic, making them difficult to solubilise in solvents that 
retain their native conformation, and because interactions between them can be highly 
transient; together, these features make it difficult to confidently interpret data from commonly-
used methods such as biochemical purifications using native material (21). To address these 
issues, we have developed an approach called AVEXIS (for AVidity-based EXtracellular 
Interaction Screening) (22), which, together with a library of functionally active recombinant 
blood-stage Plasmodium proteins (23, 24) has permitted the biochemical identification and 
characterisation of parasite protein complexes at the surface of the merozoite including the 
RH5 complex (13). Here, we use proteomic analyses of Plasmodium sporozoites to compile 
 
 





a recombinant protein library representing the cell surface receptor repertoire and secretome 
of the P. falciparum sporozoite. We use this protein library and the AVEXIS approach to 
identify interactions between sporozoite proteins and characterise their role in the 




Experiments involving animals were performed under UK Home Office governmental 
regulations (project licence numbers PD3DA8D1F and P98FFE489) and European directive 
2010/63/EU. Research was approved by the Sanger Institute Animal Welfare and Ethical 
Review Board.  
 
Design of the Plasmodium sporozoite protein library.  
To obtain a catalogue of proteins that are expressed by sporozoites, published proteomic data 
using mass spectrometry-based profiling of midgut-and salivary gland sporozoites (25-27) 
were combined to create a list of unique proteins and protein expression constructs designed 
essentially as described (23); we additionally included several proteins expressed by 
ookinetes. Briefly, cell surface and secreted proteins were initially identified by the presence 
of a signal peptide and/or transmembrane domains using SignalP v4.0 (28) and TMHMM v2.0 
(29) software. To define the ectodomain regions, signal sequences and transmembrane 
domains were removed and all potential N-linked glycosylation sites (N-X-S/T, where X is not 
proline) were systematically mutated by substituting the serine/threonine for alanine to prevent 
inappropriate glycosylation when expressed in mammalian cells. Sequences encoding the 
sporozoite protein ectodomains were codon optimised for expression in human cells and made 
by gene synthesis (GeneART). Four genes failed synthesis and three could not be subcloned 
into the mammalian expression plasmids, suggesting the insert was toxic in E. coli (Table S1). 
 
 





All sequences were flanked with unique 5’ NotI and 3’ AscI restriction enzyme sites to allow 
inframe cloning in the bait and prey plasmids (30). Both expression plasmids contain a highly 
efficient mouse variable κ light chain signal peptide and a rat Cd4d3+4 epitope tag followed 
by either a peptide sequence allowing biotinylation and 6-his tag (baits) or pentamerising 
COMP sequences followed by the beta-lactamase enzyme and a 6-his tag (preys) (31). The 
same process was followed for the P. berghei orthologues. All plasmids have been deposited 
in the Addgene plasmid repository (www.addgene.org/express). 
 
Production of the recombinant bait and prey proteins. 
All proteins were produced recombinantly as a monobiotinylated bait and a pentamerised prey 
by transient transfection of HEK293E (32) or HEK293-6E cells (33) essentially as described 
(30). All proteins were purified from the cell culture supernatant up to six days after transfection 
using Ni2+-NTA resin using either automated purification systems (GE Healthcare) or manually 
using Ni-NTA Agarose (Jena Biosciences) and dialysed extensively against HBS or PBS. 
  
Normalisation of bait and prey proteins. 
The expression levels of biotinylated bait and β-lactamase-tagged prey proteins were 
quantified essentially as described (30). Briefly, for bait proteins, serial dilutions of the purified, 
dialysed proteins were added to individual wells of a streptavidin-coated microtitre plate 
(NUNC). Proteins were captured and washed with HBS-T (HBS/0.1% Tween 20) followed by 
addition of 1 μg/mL mouse anti-rat Cd4 OX68 monoclonal antibody in HBS/0.2% BSA and 
washed with HBS-T. Proteins were detected by addition of a goat-anti-mouse alkaline-
phosphatase conjugated antibody (Sigma A4656), washing followed by addition of 1 mg/mL 
alkaline phosphatase substrate 104 dissolved in diethanolamine buffer and reading the 
absorbance at 405 nm in an automated plate reader (FluoStar Optima, BMG Labtech). For 
subsequent assays, the highest protein dilution that saturated the biotin binding capacity of 
the well was used. The activity of prey proteins was normalised by quantifying the activity of 
 
 





the β-lactamase enzyme in the prey protein tag. Serial dilutions were prepared in a 96-well flat 
bottom microtitre plate and 20 μL added to 60 μL of a 242 μM solution of the colourimetric β-
lactamase substrate nitrocefin (Cayman Chemical Company). The kinetics of substrate 
hydrolysis were followed for 20 minutes and prey proteins normalised to an activity of ~2 nmol 
min-1 for use in subsequent assays. To produce tetrameric preys to detect the CelTOS-
PF3D7_0721100 interaction, a dilution series of monomeric biotinylated protein (similar to bait 
normalisation) was incubated with 2-5 μg/mL alkaline phosphatase coupled streptavidin 
(Sigma) for 45 min to allow the formation of tetramers and then used in an ELISA as described 
above. The lowest dilution which did not give a signal at 405 nm was used for AVEXIS. 
  
Western blotting. 
Purified proteins were resolved by SDS-PAGE using Novex NuPAGE 4–12% Bis Tris precast 
gels (Life Technologies). Proteins were reduced by adding NuPAGE reducing agent to the 
sample and antioxidant (Life Technologies) to the gel running buffer according to the 
manufacturer’s instructions. Proteins were blotted onto nitrocellulose membranes (Life 
Technologies) and protein binding sites blocked using a 2% BSA solution. Biotinylated 
proteins were detected by incubating membranes with High sensitivity Streptavidin-HRP 
(PIERCE), washing and addition of SuperSignal West Pico Chemiluminescent substrate 
(PIERCE) and developed on photographic film. 
 
Enzyme-linked immunosorbant assay (ELISA)  
ELISAs were performed by capturing biotinylated bait proteins into individual wells of 
streptavidin-coated 384-well plates (NUNC). Plates were washed for 30 mins with 50 μL PBS-
T (0.2% Tween) and blocked with PBS-2% BSA for a minimum of 3 hours. 20 μL of a bait 
protein diluted in PBS-2% BSA at a concentration previously determined as the amount 
required to saturate the biotin binding capacity of the well were added in triplicate and 
incubated for at least 16 hours at 4°C. Where required, a similar set of bait protein dilutions 
 
 





were heat inactivated for 30 min at 70 °C. Antisera from pooled Malawian adults (23) were 
centrifuged at 13,000 rpm for a minimum of one hour, diluted in PBS-2% BSA and incubated 
with rocking for at least 16 hours at 4°C before adding to the antigen-coated plates for one 
hour. Plates were washed 3x in PBS-T before addition of a 1:10,000 dilution of rabbit-anti-
human polyvalent IgG/A/M (Sigma I8010) in PBS-2% BSA for one hour, and washed in PBS-
T, followed by 1:10,000 dilution of goat anti-rabbit Poly-HRP IgG/A/M (PIERCE) in PBS-2% 
BSA for one hour. Plates were washed in PBS-T and the HRP substrate ABTS (KPL) was 
added and absorption at 405 nm determined using an automated plate reader (FluoStar 
Optima, BMG Labtech).  
 
AVidity-based EXtracellular protein Interaction Screening assay 
Systematic screening for protein interactions was performed essentially as described 
previously (22, 34). Briefly, normalised bait proteins were immobilised on streptavidin-coated 
96-well microtitre plates (NUNC) and activity-normalised prey proteins added to the arrayed 
bait proteins and incubated at room temperature for 1 hour. The plates were washed twice in 
HBS-T (0.2% Tween 20) and once in HBS before 60 μL of 125 μg/mL nitrocefin (Cayman 
Chemical Company) was added and the absorbance measured at 485 nm in a plate reader. 
When tetramerised preys were used, 1 mg/mL phosphatase substrate 104 in diethanolamine 
buffer was added and the absorbance measured at 405 nm. The rat Cd200-Cd200R 
interaction was used as a positive control, and a biotinylated Ox68 antibody which recognises 
the Cd4-tag in the prey was used as a prey capture control. Some bait and prey proteins 
showed low levels of promiscuous binding in the screen (e.g. bait 56 and prey 27) but because 
of their lack of specificity and weak binding signals, were not investigated further. 
 
Experimental Design and Statistical Rationale 
The goal of the protein interaction screening was to identify directly interacting proteins within 
the library of recombinant P. falciparum sporozoite membrane proteins. Sixty-four bait proteins 
 
 





were tested for interactions against 54 prey proteins; however, there was insufficient amounts 
of one of the baits (protein 53 - SIAP-1) and therefore this bait was tested against 35 prey 
proteins. In total, 3,437 binding tests were performed: 46 proteins were present in both prey 
and bait libraries and therefore tested in both bait-prey orientations; the other proteins were 
consequently tested in one orientation, making a total of 2,379 unique interactions tested. The 
initial screen was performed once but the identified interactions were repeated in triplicate and 
further characterised using surface plasmon resonance. Control baits and preys were present 
in all experiments; typically the rat Cd200-CD200R interaction is used as a positive control. 
Data are shown as mean absorbance readings with standard deviations to show 
reproducibility between replicates.   
 
Surface Plasmon Resonance 
A Biacore 8K instrument (GE Healthcare) was used for the surface plasmon resonance studies 
essentially as described (35). In brief, biotinylated bait proteins were immobilised on a 
streptavidin-coated sensor chip (GE Healthcare). Approximately 400 RUs of the control bait 
(biotinylated rat Cd4d3+4) were immobilised in the flow cell used as a reference and the 
approximate molar equivalents of the query protein immobilized in the other flow cells. Purified 
analyte proteins were resolved by size exclusion chromatography on a Superdex 200 Increase 
10/300 column (GE Healthcare) in HBS-P (10 mM HEPES, 150 mM NaCl, 0.05% v/v P20 
surfactant) immediately before use in SPR experiments thereby removing any aggregated 
protein that might influence kinetic measurements. The surface was regenerated with a pulse 
of 2 M NaCl at the end of each cycle, and all experiments were performed at 37°C. Duplicate 
injections of the same concentration in each experiment were superimposable demonstrating 
no loss of activity after regenerating the surface. Binding data were analysed in the 
manufacturer's Biacore 8K evaluation software version 1.1 (GE Healthcare). 
 
Cloning and expression of P. berghei orthologues 
 
 





The P. berghei orthologues of the six identified interacting P. falciparum proteins were 
identified using PlasmoDB (36). Sequences were modified in the same way described in 
Design of the Plasmodium sporozoite protein library and the genes synthesised by GeneART. 
The synthetic plasmids were digested with NotI and AscI restriction enzymes (NEB) and were 
each subcloned into the bait and prey vectors. Recombinant proteins were produced by 
transient transfection of HEK293-E or 6E cells as described above. 
  
P. berghei genetic targeting. 
P. berghei targeting plasmids for PIESP15 (PBANKA_0209200, PbGEM-268595) and 
PBANKA_0800600, PbGEM-331155 were obtained from the PlasmoGEM vector resource 
(plasmogem.sanger.ac.uk) (37). To make targeting plasmids that disrupt the 
PBANKA_0522500 and PBANKA_1241700 loci, oligonucleotides were designed to amplify 5’- 
and 3’ homology regions of each gene. Each homology arm was approximately 1 kbp long 
and spans the 5’ UTR into the open reading frame, and from inside the open reading frame 
into the 3’UTR of each gene respectively. Restriction sites were added to the primer sequence 
to enable cloning of the PCR products. PCRs were done using Kapa HiFi HotStart Ready Mix 
(Kapa Biosciences) and genomic DNA isolated from P. berghei GFP-LUC parasites (38) was 
used as a template. PCR conditions were 5 min at 95°C followed by 35 cycles of 95°C for 30 
sec, 55°C for 30 sec and 68°C for 1-3.5 min and a final extension of 10 min at 68°C. PCR 
products were sequentially cloned into the KpnI and XmaI or the XhoI and SacII restriction 
sites of the pR6K attL1-3xHA-hDHFR-yfcu-attL2 plasmid backbone (39) and used to transfect 
P. berghei parasites.  
 
Transfection and cloning by limiting dilution 
Recombinant parasites were generated by transfecting a parental “wild-type” transgenic P. 
berghei strain expressing green fluorescent protein (GFP) and luciferase (38). Transfections 
were done essentially as described (40). Briefly, 6-12 week old Balb/C or Theiler’s original 
 
 





(TO) mice were used for routine propagation of the parasites. Prior to transfection, 10 μL DNA 
were digested with NotI restriction enzyme (NEB) overnight at 37 °C to release the transfection 
cassette from the plasmid backbone. DNA was purified by ethanol precipitation and 
resuspended in 10 μL dH2O. Parasites were cultured in vitro for 20-22 hours to obtain 
synchronised schizonts. Schizonts were purified using a 55% Nycodenz (Sigma)/PBS gradient 
and washed once in RPMI1640 medium. Pelleted schizonts were resuspended in P3 Primary 
cell Nucleofector (Lonza, 18 μL/transfection) and 25 μL of this mix was added to 5 μL of 
digested DNA. 20 μL of the mix was then added to an individual well of a 16-well 
NucleocuvetteTM Strip and pulsed using the AMAXATM 4D-Nucleofector electroporator, 
programme FI-115. Parasites were immediately resuspended in 100 μL incomplete RPMI1640 
medium and injected into the tail vein of Balb/c mice. The following day in the morning, 
pyrimethamine (0.07mg/ml, pH 4.5) was added to the drinking water for parasite selection. 
Blood smears were taken from day 7 after transfection to monitor parasitaemia and when 
parasitaemia reached 0.5-1%, blood was collected for stocks and genotyping. Subsequently, 
a drop of blood was taken from a mouse infected with the transfected parasites and parasites 
were cloned by limiting dilution. Clonality (absence of the WT locus) was confirmed by 
genotyping and cloned parasites were then used for experiments. 
 
Genotyping of P. berghei parasites for validation of gene disruption  
To confirm integration of the transfection cassette into the genome of the parasite, we 
designed specific oligonucleotides for each target gene, annealing to the chromosome just 
outside the homology arm of the plasmid (primer GT). This was paired with a universal primer 
which anneals to the yfcu cassette in the targeting plasmid (primer GW2a or b). To detect 
absence or presence of the WT locus, a gene specific primer located inside the gene sequence 
of the target gene (primer QCR1) was paired with a reverse primer in the homology arm 
(QCR2). Primers GW2 and QCR2 were then combined to detect the transfection plasmid, 
which could be either integrated or not integrated in the genome. Because the product size for 
 
 





the primer combination PbPIESP15-GW2+GT was too large, two PCR reactions were done 
to amplify one half of the fragment each. Therefore, primer GW2b was combined with primer 
PIESP15-rev2 and primer GT was combined with primer PbPIESP15-fwd2. Sequences for 
primers QCR1, QCR2 and GT for PbANKA_0800600 and PbPIESP15 were obtained from the 
PlasmoGEM web page. All primer sequences are listed in Table S2. PCR reactions were 
performed using Kapa HiFi HotStart Ready Mix (Kapa Biosciences) and cycling conditions 
were 5 min at 95°C followed by 35 cycles of 95°C for 30 sec, 55°C for 30 sec and 68°C for 1-
3.5 min and a final extension of 10 min at 68°C. Samples were separated on a 0.8% Agarose 
gel using Hyperladder 1kb (Bioline) as a size standard. 
 
In vivo phenotyping of transgenic P. berghei parasites 
Anopheles stephensi mosquitoes were allowed to feed on anaesthetised P. berghei infected 
Balb/C mice for no more than 15 min and placed in an incubator at 19°C thereafter. Nine to 
eleven days after infection, mosquitoes were anaesthetised and kept on ice and midguts were 
dissected in PBS. Only mosquitoes with developed eggs were dissected to ensure mosquitoes 
had taken a blood meal at the time of feeding. Images were taken by fluorescence microscopy 
and used to quantify GFP-positive oocysts. Oocysts were counted manually using the cell 
counter plugin in ImageJ 1.45s software. To quantify the number of sporozoites in salivary 
glands, mosquitoes were anaesthetised 21 days after infection and salivary glands dissected 
in PBS. Salivary gland sporozoites from 15 to 20 mosquitoes were released by homogenising 
the glands with a micropestle and salivary gland debris were pelleted by centrifugation for 5 
min at 100g. Sporozoites were subsequently counted in a haemocytometer. Groups of four 
mice were infected by intravenous injection of 5000 salivary gland sporozoites per mouse and 
the development of the parasites was followed in the whole animal every 24 hours for 72-96 
hours by IVIS imaging. For imaging, mice were injected with 200 μL D-luciferin (30 mg/mL in 
DPBS, Source Biosciences) and imaged under isoflurane anaesthesia 10 min later using an 
IVIS Spectrum Imaging System (Perkin Elmer).  
 
 





Once parasites were observed in the blood by IVIS (usually 72 hours post sporozoite 
injection), thin blood smears were taken daily for a minimum of five days and stained using 
Giemsa to monitor blood stage parasitaemia. To determine parasitaemia, at least 500 red 
blood cells were counted and parasitaemia calculated as a percentage of infected red blood 
cells per total number of red blood cells; percentages were then used for growth curves.  
  
Production of polyclonal antisera  
For the production of polyclonal antisera, proteins were expressed as non-biotinylated 
monomers by transient transfection of HEK293 cells, purified using the C-terminal his tag, and 
dialysed against PBS. For immunisation, 50 μg protein per animal was adjuvanted in 
Alhydrogel (Invivogen) and delivered intraperitoneally into six to eight-week-old female Balb/C 
mice. Two subsequent boosts were given with 20 μg per animal at two and four weeks after 
the initial injection. Sera were obtained one week after the final immunisation boost by cardiac 
bleed and centrifugation of the whole blood after clotting. 
 
P. falciparum cell invasion assays 
HC-04 cells were routinely cultured in Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-
12 (DMEM-F12; ThermoFisher Cat#31330038), supplemented with 10% heat inactivated fetal 
bovine serum and 1x Penicillin/Streptomycin. These cells are incubated at 37°C under 5% 
CO2 and are split using trypsin when 80% confluency is reached. 12 hours before the assay, 
50,000 cells per well were seeded in a collagen coated 96-well flat-bottom plate (Corning Cat# 
CLS3603-48EA). On the day of the experiment, salivary glands of P. falciparum NF-135 
infected mosquitoes were dissected in 1ml DMEM-F12 media and crushed using a glass 
pestle to liberate the sporozoites. Sporozoite numbers were determined using a 
hemocytometer. Media from each of the hepatocyte-seeded wells was removed and replaced 
with media containing 50,000 sporozoites per well. The plate was centrifuged at 3000 rpm for 
10 minutes and incubated at 37°C under 5% CO2 for 3 hours. After three hours, supernatant 
 
 





was removed and each well rinsed three times with PBS and trypsinized for 5 minutes to obtain 
single cell suspension. The trypsinized sample was neutralised in equal volumes of PBS 
supplemented with 10% FCS and transferred to a 96-well V-bottom plate (Costar Cat#3897). 
Samples were spun down at 1700 rpm for 4 minutes. Supernatants were removed and pellets 
were resuspended in fixation reagent as per manufacturer’s instructions (eBioscienceTM 
Foxp3/Transcription factor staining buffer set; ThermoFisher Cat# 00-5523-00) and incubated 
at 4°C for 30 minutes. Permeabilization buffer was added to each well after the incubation and 
the samples were pelleted at 1700 rpm for 4 minutes. The supernatant was removed, the pellet 
was resuspended in permeabilization buffer containing 3SP2 (antibody against PfCSP 1:400 
dilution) conjugated to FITC and incubated at at 4°C for 30 minutes. Permeabilization buffer 
was added to each well after the incubation and the samples were pelleted at 1700 rpm for 4 
minutes. Supernatant was removed and the pellets were resuspended in 1% 
paraformaldehyde in PBS. Each sample was read by fluorescent activated cytometry sorting 
(FACS) to determine the percentage of FITC-positive (infected) cells. 
 
Immunostaining of P. berghei sporozoites 
To determine the amount and subcellular localisation of CSP, salivary gland sporozoites 
were dissected from infected A. stephensi mosquitoes 21-30 days after blood feeding on P. 
berghei infected mice. Sporozoites were isolated by homogenising the glands with a 
micropestle and centrifugation for 5 min at 100g to pellet salivary gland debris. Sporozoites 
were subsequently counted in a haemocytometer and 10,000 sporozoites each were placed 
onto round 13mm coverslips and air dried. Coverslips were then stored at -80°C with 
dessicant until used for immunostaining. For immunostaining, the coverslips were left to 
reach room temperature before being removed from the bag containing desiccant. 
Coverslips were then placed into individual wells of a 24-well plate (Nunc) and parasites 
were fixed with a 4% formalin solution in PBS for 10 mins on ice. After washing twice in PBS, 
the coverslips were incubated with 0.1% Triton in PBS on ice for 15 min to permeabilise the 
 
 





parasites. All slides were washed twice in PBS, 1% BSA (Sigma) and incubated with anti-
CSP monoclonal antibody, 1:1000 in PBS, 1% BSA for 1 hour at room temperature. After 
washing three times in PBS, 1% BSA parasites were incubated with Cy3 goat anti-mouse 
IgG (Life Technologies A10521), 1:500 in PBS, 1% BSA for 30 min at room temperature, 
protected from light. Coverslips were subsequently washed in PBS, 1% BSA and mounted 





A library of P. falciparum sporozoite surface and secreted proteins 
To create a recombinant protein library representing the cell surface receptor repertoire and 
secretome of the P. falciparum sporozoite, we analysed published proteome and 
transcriptome datasets from both P. falciparum and P. yoelii sporozoites (25, 26, 41). To 
identify proteins that are likely to be displayed on the surface of the sporozoite or secreted, we 
selected those that contain a predicted N-terminal signal peptide and/or transmembrane 
domain using a set of bioinformatic tools. The resulting list of 102 proteins included 57 proteins 
that contained one or more transmembrane-spanning regions, 11 that encoded a C-terminal 
hydrophobic sequence for the addition of a glycosylphosphatidylinositol (GPI) lipid anchor, 
and 34 that had no obvious way of being tethered to a membrane, and so were predicted to 
be secreted (Table S1). Of these 102 proteins, 25 are also known to be expressed on the 
blood stages (such as P38, RhopH3 and MSP1) and already represented within our library of 
previously published merozoite proteins (23, 24). For the remaining 77 proteins, we designed 
expression constructs in a similar manner by truncating the proteins just prior to the predicted 
transmembrane region or GPI-anchor, and using gene synthesis to codon optimise the coding 
regions for expression in human cells (23). Out of these, 69 genes could be successfully 
 
 





synthesised and subcloned into the mammalian expression plasmid (Table S1), and were 
subsequently expressed as Cd4d3+4-tagged enzymatically monobiotinylated bait proteins by 
transient transfection of suspension-grown HEK293 cells. Using this approach, 58 out of the 
69 proteins (84.1%) could be detected after his-tag purification from the spent cell culture 
medium by ELISA. As is typical for this approach, for those proteins that were detectably 
expressed, levels varied widely across several orders of magnitude, but could be as high as 
~50 µg/mL for proteins such as TRAP and CSP. Forty-eight proteins could be produced in 
sufficient quantities to be used in the subsequent experiments and were resolved by SDS-
PAGE and detected by anti-biotin Western blotting to determine their integrity (Fig. 1). With 
the exception of three proteins, PSOP7, B9 and PF3D7_0624400, whose major species was 
smaller than expected, the proteins were expressed at the expected mass, although some 
proteins did show evidence of being processed. Those proteins that could not be detected or 
were expressed at very low levels included proteins that localise to the rhoptries (RALP1, 
ARNP and MAEBL), both the LCCL-domain containing secreted proteins LAP2 and LAP4, two 
members of the TRAP family (CTRP and TREP) and two members of the 6-cys family that are 
also expressed on gametes (P47 and P48/45). We have previously observed that proteins 
localised to the rhoptries of merozoites are also poorly expressed in this system suggesting 
that a rhoptry-specific chaperone may be required for expression using this approach (23).  
 
The recombinant sporozoite proteins are immunoreactive and contain 
conformational epitopes 
 
To systematically evaluate which of the recombinant proteins within the sporozoite library 
contained conformational epitopes, we quantified the immunoreactivity to purified 
immunoglobulins pooled from adult donors living in a P. falciparum malaria-endemic region. 
Over half (35/60, 58%) of the proteins were recognised by the pooled immune serum (Fig. 2). 
We found that the overall immunoreactivity to sporozoite antigens was lower than for 
 
 





merozoite antigens (23), as expected given that the immune system is exposed to many 
orders of magnitude fewer sporozoites than merozoites during an infection. The most 
immunoreactive proteins were those whose expression is not restricted to the sporozoite stage 
but which are also expressed during the blood stages. Sporozoite proteins that are not 
expressed by the blood stages generally exhibited a lower immunoreactivity with CSP, 
PIESP15, ETRAMP8, and three conserved proteins with unknown function: PF3D7_0702900, 
PF3D7_0713700 and PF3D7_0505700, being the most immunodominant. Except for CSP, 
the immunoreactivity of the immune serum to heat-treated proteins was either completely lost 
or reduced compared to the untreated proteins, demonstrating that the immune serum was 
recognising conformational epitopes and suggesting that most proteins were folded (Fig. 2). 
The lack of heat-labile epitopes in recombinant CSP is consistent with the known 
immunodominance of the repetitive “NANP” repeats which are predicted to be natively 
unstructured (42). These data demonstrate that the majority of soluble recombinant P. 
falciparum sporozoite proteins expressed in mammalian cells contain conformational epitopes 
and represent a valuable resource for studying the molecular pathology of P. falciparum 
infections.  
 
Identification of P. falciparum sporozoite surface protein complexes by 
systematic protein interaction screening  
To identify P. falciparum sporozoite extracellular protein complexes we used the AVEXIS 
assay which detects direct interactions between soluble recombinant ectodomains expressed 
as biotinylated bait and highly avid enzyme-tagged prey proteins (22). To produce the 
sporozoite library as prey proteins, the ectodomains were subcloned into a plasmid containing 
tags for pentamer formation and expressed in HEK293 cells. As expected, the levels of activity 
varied and 54 prey proteins were expressed at sufficient levels after their activities had been 
normalised to the threshold level required for the AVEXIS assay (Table S1). In total, 64 bait 
proteins were systematically tested for interactions against the 54 prey proteins (Fig. 3A). One 
 
 





of the baits (SIAP-1 - protein 53) was expressed at low levels and therefore tested against just 
35 prey proteins so that a total of 3,437 binding tests were performed. Forty-six of the proteins 
were present in both bait and prey libraries and consequently tested in both bait-prey 
orientations; the remaining proteins were therefore tested in a single orientation only, resulting 
in a total of 2,379 unique interactions tested. We identified three interactions: the first between 
a type I cell surface protein called PIESP15 and a secreted protein: PF3D7_0702900; a 
second between two members of the p24 family of proteins (PF3D7_0422100 and 
PF3D7_0526900), and the third between CelTOS and a predicted secreted protein 
(PF3D7_0721100). The PIESP15-PF3D7_0702900 and p24 family interactions were 
identified in both bait-prey orientations in the initial screen; however, because the 
PF3D7_0721100 protein did not express at sufficient levels in the prey format, the CelTOS-
PF3D7_0721100 interaction was initially identified in one orientation. For those five prey 
proteins that interacted with a specific bait, we repeated the binding assays against all the 
baits in triplicate and confirmed the interactions (Fig. 3B). The interaction between CelTOS 
and PF3D7_0721100 was confirmed using a modified assay where monomeric biotinylated 
proteins were clustered around an alkaline phosphatase-streptavidin conjugate to form avid 
tetrameric preys, which then could be used to probe immobilised baits to test for interactions 
(43). Using this method, we could show binding of CelTOS and PF3D7_0721100 in both 
orientations relative to controls (Fig. S1).  
 
The interactions are conserved between orthologous proteins in P. berghei  
To further characterise these interactions, we first used surface plasmon resonance (SPR) to 
establish whether the proteins could directly interact and quantify their biophysical binding 
parameters. For each interacting pair, one protein was purified and serial dilutions injected 
over its binding partner expressed as a biotinylated protein and immobilised on a streptavidin-
coated sensor chip. Clear binding was observed for each interaction and the association and 
dissociation binding parameters were quantified by fitting the series of binding traces to a 1:1 
 
 





binding model (Fig. 4A). As expected, the two interactions involving a protein predicted to be 
secreted exhibited slower dissociations than the membrane-tethered p24 complex proteins 
(21). Genome analysis revealed that the six proteins forming complexes had identifiable 
orthologues in the genomes of all Plasmodium species sequenced to date (36). To determine 
if the protein interactions were conserved across species, we expressed the orthologues of 
these proteins from the rodent parasite P. berghei as both baits and preys and tested if they 
could directly interact using the AVEXIS assay. We could detect robust interactions between 
PbPIESP15 and PbANKA_0800600 and the two P. berghei p24 complex proteins in both bait-
prey orientations (Fig. 4B, C). We were unable to determine if the interaction between CelTOS 
and PF3D7_0721100 was conserved between the P. berghei orthologues of these proteins 
because repeated attempts to produce the P. berghei orthologue of PF3D7_0721100 failed; 
therefore, this interaction was not investigated further. These data demonstrate evolutionary 
conservation of the interaction interfaces, which is striking since the amino acid sequence 
identity of the extracellular regions was relatively modest: 58 and 64% for the two p24 complex 
proteins; and 42 and 75% for PIESP15 and PF3D7_0702900 respectively. We next sought to 
characterise the biochemical interaction between PIESP15 and PF3D7_0702900 in more 
detail. Both proteins contain recognisable protein domains in their extracellular regions: 
PIESP15 has an L-type lectin domain, so named because it has homologies to lectins found 
in leguminous plants (44), and PF3D7_0702900 contains tandem EF-hand domains. It 
seemed unlikely that the PIESP15- PF3D7_0702900 interaction involved carbohydrate 
binding because Plasmodium parasites lack the glycosyltransferase enzymes necessary for 
complex carbohydrate modifications (45, 46), and because of the design of the recombinant 
proteins the only predicted glycosylation was present within the Cd4 protein tag common to 
all bait proteins. Both L-type lectin and EF hand domains are known to require calcium ion 
cofactors in their binding sites (47, 48), and consistent with this we observed that the PIESP15- 
PF3D7_0702900 interaction was inhibited in a dose dependent manner in the presence of the 
divalent ion chelator, EDTA (Fig. 4D).  
 
 






Both genes encoding p24 complex proteins are required for P. berghei liver 
stage infection 
The cross-species conservation of both the PIESP15-PF3D7_0702900 and p24 complex 
protein interactions suggested that P. berghei was a suitable and experimentally tractable 
model, and enabled us to further validate these interactions by asking if parasites lacking 
genes encoding interacting proteins had similar infection phenotypes. To make gene-deficient 
parasites for all four genes, we used existing plasmids from the PlasmoGEM resource to target 
both PbANKA_0800600 and PIESP15 (49). Gene targeting plasmids for the P. berghei 
orthologues of both p24 complex genes, PBANKA_1241700 and PBANKA_0522500, were 
not available, so these were designed and constructed (Fig. S2). Gene-deficient parasites for 
all four genes were made by electroporating erythrocytes infected with a GFP-luciferase-
transgenic “wild-type” P. berghei parental line and then cloned by limiting dilution. Parasites 
were genotyped to confirm recombination at the targeted locus (Fig. S2B, C, Fig. S3). 
Mosquitoes were infected with the cloned parasite lines and the infection was quantified 
throughout the life cycle in both the mosquito vector and mammalian host. We observed that 
both the ∆PbPIESP15 and ∆PbANKA_0800600 parasite lines had no overt infection 
phenotype in either the mosquito or in mice compared to the wild-type parental line (Fig. S4). 
This lack of infection phenotype was consistent with the inability of polyclonal antibodies to 
both PIESP15 and PF3D7_0702900 to prevent invasion of P. falciparum sporozoites in human 
cells (Fig. S5). By contrast, while P. berghei parasites lacking either PBANKA_1241700 or 
PBANKA_0522500 infected mosquitoes indistinguishably from the wild-type line (Fig. 5A, B), 
intravenous infections of mice with salivary gland sporozoites resulted in a striking reduction 
in the number of parasites in the liver stage of infection for both genes (Fig. 5C, D). This was 
confirmed by a significant delay in the appearance of parasites in the blood of infected mice 










In this study we have compiled a library of soluble recombinant forms of the membrane-
embedded and secreted proteins from the P. falciparum sporozoite. We have shown how this 
resource can be used to characterise the host humoral immune response in malaria patients 
and identify protein complexes that are important for sporozoite function. A key feature of this 
resource is that we have produced the proteins in a mammalian expression system to increase 
the chances that the proteins contain structurally-critical posttranslational modifications such 
as disulfide bonds and thereby adopt their native conformation, which is essential for retaining 
extracellular binding functions. A similar library representing the secreted and membrane-
embedded proteins from the P. falciparum merozoite has proven very valuable to define the 
serology of the infected host (50), identify both parasite-parasite (9, 13) host-parasite protein 
interactions (51-54) as well as blood stage vaccine candidate screening (55). An important 
facet of this protein library is that many antigens can be assessed in parallel so that they can 
be directly compared in a systematic manner rather than the more common testing of proteins 
individually, which introduces technical variation that makes comparison very difficult. We 
therefore envision that this resource will be an important tool for the malaria community and 
have an impact in defining a better molecular understanding of the basic infection biology of 
the P. falciparum sporozoite; ultimately, these findings will contribute towards providing new 
opportunities for therapeutic interventions.  
 
Of the three interactions we describe, the interaction between the p24 complex proteins 
PF3D7_0526900 and PF3D7_0422100 was of particular interest because P. berghei parasites 
lacking the orthologues of either of these genes exhibited strong sporozoite in vivo infection 
phenotypes. p24 proteins contain a GOLD (GOLgi Dynamics) domain and four can be readily 
identified from their primary protein sequence in Plasmodium spp. genomes. Most p24 family 
proteins are ubiquitously expressed, although some may show elevated expression in different 
 
 





developmental contexts, and at least three are abundant in sporozoites and therefore 
represented in our library. We only observed interactions between two of these three proteins 
suggesting that there is binding specificity within the family, which is most likely mediated by 
the regions of predicted coiled coil in the lumenal domain (56). p24 family proteins are mainly 
localised to the membranes of the early secretory pathway, and experiments in yeast have 
suggested that they play major roles as cargo receptors for GPI-linked proteins. Their lumenal 
(ectodomain) regions function as a lectin by binding the oligo-mannose glycans in the GPI 
anchor (57) while their short cytoplasmic tails nucleate the formation of both COPI and COPII 
vesicle coats through their dilysine and phenylalanine-containing motifs respectively (58). One 
likely molecular interpretation for the phenotypes of sporozoites lacking the interacting p24 
family proteins is that they are unable to appropriately traffic GPI-anchored proteins that are 
important for sporozoite invasion of host cells to the sporozoite surface. One obvious 
candidate is CSP, but we did not observe any obvious difference in the localisation or amount 
of CSP at the surface of sporozoites that lacked either PBANKA_1241700 or 
PBANKA_0522500 (Fig. S6). It is known that p24 family proteins are not essential for GPI-
anchored protein trafficking since an engineered yeast strain lacking all known p24 family 
proteins only has a subtle phenotype that affects the rate and fidelity of protein trafficking (59). 
This suggests that most GPI-anchored proteins in yeast necessary for laboratory growth can 
be trafficked by “bulk flow” through the secretory pathway. Perhaps because CSP is so 
abundant at the sporozoite surface, it mainly relies on bulk flow for secretion and so is not 
affected by the loss of p24 family proteins. The infection phenotype we observed may 
therefore be due to mistrafficking of one or more of the several other GPI-anchored proteins 
that are expressed by sporozoites. 
 
Of the two other interactions that we identified, we were able to show that P. berghei parasites 
genetically targeted for genes encoding the interacting proteins PIESP15 and 
PbANKA_800600 had no overt infection phenotypes, although because sporozoites were 
 
 





delivered by intravenous injection, there remains the formal possibility of a phenotype in 
sporozoite behaviour in the dermis. These findings are consistent with the lack of in vivo blood 
stage growth phenotypes for knockouts of these genes in P. berghei as part of a large scale 
genetic screen (49), as well as a previous smaller scale genetic screen focussed on identifying 
genes encoding cell surface and secreted proteins required by the ookinete to infect 
mosquitoes (60). There is proteomic evidence from several studies that these proteins are not 
restricted to sporozoites in P. falciparum but can be detected in other stages including 
gametocytes (61) and blood stages (62). Interestingly, insertional mutagenesis genetic 
screens have shown that both PIESP15 and PF3D7_0702900 are very important for in vitro 
blood stage culture in P. falciparum providing evidence that these genes may play important 
roles in P. falciparum in other lifecycle stages (63). It is worth noting that the genes encoding 
PF3D7_0702900/PbANKA_0800600 are currently annotated as a “putative centrin” in gene 
databases which appears to be a computational prediction based on very low (<30%) protein 
sequence identity. There is no functional evidence to support this claim and both 
PF3D7_0702900/PbANKA_0800600 have confident signal peptide predictions strongly 
suggesting an extracellular localisation, which would not be compatible with the required 
cytoplasmic localisations of centrin and its known role in centrosome biology. We were not 
able to further investigate the functional role of the interaction between CelTOS, a protein of 
considerable interest due to its role in mosquito infection and cell traversal (64) and 
PF3D7_0721100 in P. berghei because initial attempts to genetically target the P. berghei 
orthologue PBANKA_0618600 did not result in any recombinants and we were unable to 
express the protein in a recombinant form.  
 
In summary, we have produced a library of secreted and membrane-embedded proteins that 
are expressed by the P. falciparum sporozoite using a mammalian expression system. We 
believe that these proteins will be particularly useful to the malaria research community 
because of the challenges in obtaining large amounts of sporozoite material and solubilising 
 
 





membrane-embedded proteins in their native conformation. Given that targeting the 
sporozoite stage either as attenuated whole sporozoites or as a sporozoite surface protein-
based subunit vaccine has shown promise in malaria vaccine development (6), gaining a 
greater understanding of these proteins and how they function will advance not only a 
molecular understanding of sporozoite infection biology, but is also likely to provide important 
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Figure 1. A library of recombinant P. falciparum sporozoite cell surface and secreted 
proteins. The library of sporozoite receptor ectodomains was expressed as soluble 
recombinant enzymatically biotinylated proteins in HEK293 cells and the purified proteins 














Figure 2. The recombinant P. falciparum sporozoite proteins contain heat-labile 
conformational epitopes. The immunoreactivity of the recombinant sporozoite proteins to 
immune serum was quantified by ELISA. Biotinylated proteins were normalised and captured 
on a streptavidin-coated microtitre plate and probed with pooled immune sera from Malawian 
adults (blue). Reduced response of immune serum to heat-treated (70°C for 30 min) proteins 
(pink) demonstrates the presence of heat-labile conformational epitopes. Note that the eleven 
proteins between MSP5 and P41 that are grouped on the right of the graph are additionally 
expressed in blood-stage parasites. Bar charts show means ± SEM; n = 3. Positive 















Figure 3. Identification of three P. falciparum sporozoite complexes by systematic 
extracellular protein interaction screening. (A) The library of cell surface and secreted 
sporozoite proteins was expressed as biotinylated bait and enzyme-tagged pentameric prey 
proteins and systematically screened for interactions using the AVEXIS assay. The results are 
presented as a quantitative binding grid. The biotinylated baits (arranged vertically according 
to the numbers in Table S1) were immobilised in individual wells of streptavidin-coated 
microtitre plates and tested for direct binary interactions with the same proteins expressed as 
pentameric β-lactamase-tagged preys (arranged horizontally). Binding by specific baits is 
quantified by detecting the capture of prey proteins and hydrolysis of the colorimetric β-
lactamase substrate nitrocefin. (B) The five named prey proteins which interacted with a bait 
were re-tested in triplicate against the arrayed baits and the interactions confirmed. Controls 
were: positive (+) Cd200 bait -Cd200R prey; negative (-) Cd200 bait with corresponding 












Figure 4. Biophysical characterisation of the three sporozoite complex interactions and 
conservation of interactions with orthologous proteins in P. berghei. (A) Biophysical 
characterisation of the three P. falciparum sporozoite interactions by SPR. For each interacting 
pair, one protein was immobilised on the sensor chip and 2-fold serial dilutions of the indicated 
corresponding binding partner was injected to quantify binding parameters. The raw 
sensorgram data (black lines) were fitted to a 1:1 binding model (red lines) to derive the 
association (ka) and dissociation (kd) rates constants. (B) The entire ectodomains of the P. 
berghei orthologues of PIESP15 (PBANKA_0209200) and PF3D7_0702900 
(PBANKA_0800600), as well as PF3D7_0422100 (PBANKA_0522500) and PF3D7_0526900 
(PBANKA_1241700) (C), were expressed as both bait and prey proteins and shown to directly 
interact using the AVEXIS assay in both bait-prey orientations. The rat Cd200-Cd200R 
interaction was used as a positive control (+ve); negative control bait (-ve) was Cd200. (D) 
The PIESP15-PBANKA_0800600 interaction but not the control Cd200-Cd200R interaction 
was inhibited in a dose-dependent manner by addition of EDTA as detected by AVEXIS. Bars 











Figure 5. Both genes encoding the interacting p24 complex proteins are required for P. 
berghei mammalian host liver stage infection. (A) The number of oocysts per midgut in A. 
stephensi mosquitoes infected with P. berghei ∆PBANKA_1241700 or ∆PBANKA_0522500 
were counted and found to be not significantly different from the GFP-luciferase transgenic 
wild-type parental strain. Data points are individual midguts; median is indicated and statistical 
comparisons were performed using the Mann-Whitney Test; P-values > 0.05 were considered 
non-significant (ns). (B) Average number of salivary gland (SG) sporozoites per mosquito. 15-
20 mosquitoes were dissected and sporozoites isolated from the salivary glands were 
counted. The columns represent the average number of salivary gland sporozoites across four 
independent experiments. Columns represent the mean with SD, statistical analysis was 
performed using an unpaired t-test. (C) P. berghei ∆PBANKA_1241700 or 
∆PBANKA_0522500 parasites do not establish robust liver stage infections in mice compared 
to wild-type control. Groups of four mice were infected by intravenous administration of 5000 
isolated salivary gland sporozoites and the resulting parasitaemia quantified in the whole 
animal using luciferase-based bioluminescence using an in vivo imaging system. Data points 
are mean ± SD; n = 4. (D) Normalised bioluminescence images collected on each day after 
 
 





infection; the left-most animal in each cohort is an uninfected control. (E) The pre-patency 
period before detection of blood stage parasitaemia is significantly delayed in 
∆PBANKA_1241700 and ∆PBANKA_0522500 parasites relative to the wild-type control. WT 
animals were culled on day 7 because they showed signs of disease (indicated with a cross). 
Asexual blood stage parasitaemia was quantified by microscopic analysis of blood smears 
taken between four and eight days after infection. Shown are the results from one of two 
independent experiments with similar results. Data points are mean ± SD; n = 4. The 
prepatency period was less than four days for the parental line and 7.0 ± 0.7 (mean ± S.D. n 
= 4) for ∆PBANKA_0522500 and 7 ± 1 for ∆PBANKA_1241700. 
 
